Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR reports pain reduction in 83% of osteoarthritis patients

Oct 10, 2017 at 2:33 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment